Major Adverse Cardiovascular Events

MACE is a composite endpoint used in clinical trials to measure the combined incidence of major cardiovascular events, such as myocardial infarction, ischemic stroke, and cardiovascular death. The cordioprev-trial used this as a primary measure of efficacy.